Related Experiment Video
Updated: Aug 9, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Sources of cardiomyocytes for stem cell therapy: an update
Pasquale Gallo1, Cesare Peschle, Gianluigi Condorelli
1Department of Medicine, University of California, San Diego, 92003, USA.
Abstract:
The therapeutic use of stem cells for cardiac repair following myocardial infarction (MI) has generated a great deal of interest. Many types of stem/progenitor cells have been used in an attempt to regenerate the infarcted heart. We have reviewed the current state of progress using embryonic stem (ES) cells, hematopoietic stem and progenitor cells (HSCs/HPCs), mesenchymal stem and progenitor cells, resident and cardiac "stem" cells from other sources. Our view is that, even though the road ahead is long and tortuous, embryonic stem cells represent the most reliable font of CMC and the most promising type of cell to rely on for a future tool in heart failure treatment.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Mesenchymal Stem Cells
iPS Cell Differentiation

